Expansion of CD5- B cells in multiple sclerosis correlates with CD80 (B7-1) expression

Scandinavian Journal of Immunology

Volumn 56, Issue 1, 2002, Pages 101-107

  Sellebjerg, F ^a,b   Jensen, J ^a   Jensen, C V ^a   Wiik, A ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B7 ANTIGEN; CD5 ANTIGEN; IMMUNOGLOBULIN G; MYELIN PROTEIN; PROTEIN ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CEREBROSPINAL FLUID; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD5; ANTIGENS, CD80; AUTOANTIBODIES; B-LYMPHOCYTE SUBSETS; FEMALE; HUMANS; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; MYELIN PROTEOLIPID PROTEIN;

EID: 0036422343     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2002.01108.x     Document Type: Article

References (44)

1. Andersson M, Alvarez Cermeno J, Bernardi G et al. Cerebrospinal fluid in the diagnosis of multiple sclerosis: A consensus report. J Neurol Neurosurg Psychiatry 1994;57:897-902.
2. Lucchinetti CF, Brück W, Rodriguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996;6:259-74.
3. Sellebjerg F, Jensen CV, Christiansen M. Intrathecal IgG synthesis and autoantibody secreting cells in multiple sclerosis. J Neuroimmunol 2000;108:207-15.
4. Schuller E, Delasnerie N, Lebon P. DNA and RNA antibodies in serum and CSF of multiple sclerosis and subacute sclerosing panencephalitis patients. J Neurol Sci 1978;37:31-6.
5. Dore-Duffy P, Donaldson JO, Rothman BL, Zurier RB. Antinuclear antibodies in multiple sclerosis. Arch Neurol 1982;39:504-6.
6. Singh VK. Detection of antinuclear antibody in the serum of patients with multiple sclerosis. Immunol Lett 1982;4:317-9.
7. Barned S, Goodman AD, Mattson DH. Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology 1995;45:384-5.
8. Collard RC, Koehler RPM, Mattson DH. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology 1997;49:857-61.
9. Tourbah A, Clapin A, Gout O et al. Systemic autoimmune features and multiple sclerosis. A 5-year follow-up study. Arch Neurol 1998;55:517-21.
10. Hardy AA, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001;19:595-621.
11. Mix E, Olsson T, Correale J et al. B cells expressing CD5 are increased in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol 1990;79:21-7.
12. + B cells and CD4-8-T cells in neuroimmunological diseases. J Neuroimmunol 1991;32:123-32.
13. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med 2000;191:883-90.
14. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-31.
15. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
16. Sellebjerg F, Christiansen M. Qualitative assessment of intrathecal IgG synthesis by isoelectric focusing and immunodetection: Interlaboratory reproducibility and interobserver agreement. Scand J Clin Lab Invest 1996;56:135-43.
17. Sellebjerg F, Jensen J, Ryder LP. Costimulatory CD80 (B7-1) and CD86 (B7-2) on cerebrospinal fluid cells in multiple sclerosis. J Neuroimmunol 1998;84:179-87.
18. Jacobsen S, Halberg P, Ullman S et al. Clinical features and serum antinuclear antibodies in 230 Danish patients with systemic sclerosis. Br J Rheumatol 1998;37:39-45.
19. Wiik A, Rasmussen N, Wieslander J. Methods to detect autoantibodies to neutrophilic granulocytes. In: Maini, RN, van Venrooij, WJ, eds. Manual of Biological Markers of Disease. Dordrecht, Kluver: Academic Publishers, 1993;1-14.
20. Veitorp M, Høier-Madsen M, Halberg P. Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor. Scand J Rheumatol 1979;8:63-70.
21. Mouritzen S, Høier-Madsen M, Wiik A, Ørum O, Petersen NS. The specificity of anti-cardiolipin antibodies from syphilis patients and from patients with systemic lupus erythematosus. Clin Exp Immunol 1989;76:178-83.
22. Sellebjerg F, Madsen HO, Frederiksen JL, Ryder LP, Svejgaard A. Acute optic neuritis: Myelin basic protein and proteolipid protein antibodies, affinity, and the HLA system. Ann Neurol 1995;38:943-50.
23. Frederiksen JL, Larsson HBW, Christiansen P, Sellebjerg FT, Olesen J. Blood-brain barrier impairment in acute optic neuritis evaluated by gadolinium-DTPA enhanced MRI and CSF studies. Eur J Neurol 1996;3:560-6.
24. Paty DW, Oger JJ, Kastrukoff LF et al. MRI in the diagnosis of MS: A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988;38:180-5.
25. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991;351:662-4.
26. Freedman AS, Freeman G, Whitman J et al. Expression and regulation of CD5 on in vitro activated human B cells. Eur J Immunol 1989;19:849-55.
27. Defrance T, Vanbervliet B, Durand I, Banchereau J. Human interleukin 4 down-regulates the surface expression of CD5 on normal and leukemic B cells. Eur J Immunol 1989;19:293-9.
28. Lankester AC, van Schijndel GMW, Cordell JL, van Noesel CJM, van Lier RAW. CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 1994;24:812-6.
29. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996;274:1906-9.
30. Kaveri SV, Lacroix-Desmazes S, Mouthon L, Kazatchkine MD. Human natural autoantibodies: Lessons from physiology and prospects for therapy. Immunologist 1998;6:227-33.
31. Hayakawa K, Asano M, Shinton SA et al. Positive selection of natural autoreactive B cells. Science 1999;285:113-6.
32. - B lymphocyte subset producing natural antibodies. J Immunol 1992;148:2690-702.
33. + B cells and increased intestinal permeability. Dig Dis Sci 1996;41:2493-8.
34. Lenschow D J, Walunas TL, Bluestone JA. CD28/137 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
35. Bar-Or A, Oliveira EML, Anderson DE et al. Immunological memory: Contribution of memory B cells expressing costimulatory molecules in the resting state. J Immunol 2001;167:5669-77.
36. Sørensen TL, Roed H, Sellebjerg F. Chemokine receptor expression on B cells and effect of interferon-β in multiple sclerosis. J Neuroimmunol 2002;122:125-31.
37. Ziola B, Reunanen M, Salmi A. IgM-class rheumatoid factor in serum and cerebrospinal fluid of multiple sclerosis and matched neurological control patients. J Neurol Sci 1981;51:101-9.
38. D'Olhaberriague L, Levine SR, Salowich-Palm L et al. Specificity, isotype, and tier distribution of anticardiolipin antibodies in CNS diseases. Neurology 1998;51:1376-80.
39. Spadaro M, Amendolea MA, Mazzucconi MG et al. Autoimmunity in multiple sclerosis: Study of a wide spectrum of autoantibodies. Mult Scler 1999;5:121-5.
40. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K. Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 1993;88:184-9.
41. Matsiota P, Blancher A, Doyon B et al. Comparative study of natural autoantibodies in the serum and cerebrospinal fluid of normal individuals and patients with multiple sclerosis and other neurological diseases. Ann Inst Pasteur Immunol 1988;139:99-108.
42. Karussis D, Leker RR, Ashkenazi A, Abramski O. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity? Ann Neurol 1998;44:629-34.
43. Ijdo JW, Conti-Kelly AM, Greco P et al. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 1999;8:109-15.
44. Roussel V, Yi F, Jauberteau MO et al. Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: A study of 89 patients. J Autoimmun 2000;14:259-65.